Validation of post-acidification p24 antigen as a prognostic marker for HIV disease progression

Abstract

The HIV p24 antigen has demonstrated predictive value for HIV disease progression independent of CD4 count. An acidification procedure has resulted in 40–70 percent p24 antigen positivity across HIV clinical stages, although the predictive value of post-acidification p24 antigen for disease progression has not been fully validated. We hypothesized that there would be significant differences in p24 antigen positivity between matched cohorts of rapid progressors (RP) and slow progressors (SP). Seven hundred sixteen people enrolled in the USAF HIV Natural History Study were stratified according to the slope of CD4 change over time. RP were defined as people in the fastest 15 percent of CD4 decline who also progressed at least 2 Walter Reed (WR) stages. SP were defined as people in the slowest 15 percent of CD4 decline who did not progress more than 1 WR stage. Twenty-five RP were matched to 25 SP based on initial CD4 count (median CD4 RP=750, SP=720), WR stage, age, and duration of follow-up (RP=1086 das, SP...